Safety of Growth Hormone Treatment

Journal Title: Journal of Clinical Research in Pediatric Endocrinology - Year 2009, Vol 1, Issue 1

Abstract

Growth hormone (GH) is being used in the treatment of GH deficiency and in the treatment of other conditions with increasing frequency. Several uncommon potentially adverse events including idiopathic intracranial hypertension (IIH), slipped capital femoral epiphysis (SCFE), increase in the number of pigmented nevi, gynecomastia, scoliosis, insulin resistance and a possible increase in malignancy have been associated with GH treatment. Despite its potential adverse effects, GH has had a good safety record up to now. This review will focus on the potential side effects of GH treatment in GH and non-GH deficient conditions. DOI: 10.4008/jcrpe.v1i1.8

Authors and Affiliations

Feyza Darendeliler

Keywords

Related Articles

The relationship between serum ghrelin levels and hair zinc concentrations in children

Background: Zinc (Zn) plays a central role in the activation of numerous enzyme systems that synthesize and degrade bioactive peptides. Some of these bioactive peptides, also called neuropeptides, are involved in the reg...

Prevalence and Correlates of Obesity in Schoolchildren from the City of Bursa,Turkey

Background and objectives: The prevalence of childhood obesity has been dramatically increasing worldwide. This study was performed to examine the prevalence and etiological factors of obesity in children aged 6-12 years...

Foreword

In presenting this first issue of the Journal of Clinical Research in Pediatric Endocrinology (JCRPE), we renew our hopes that in due time this journal will establish its place in the international arena of Pediatric End...

Controversies in the Definition and Treatment of Idiopathic Short Stature (ISS)

The term idiopathic short stature (ISS) refers to short children with no identifiable disorder of the growth hormone (GH)/insulin like growth factor (IGF) axis and no other endocrine, genetic or organ system disorder. Th...

Ghrelin Levels and Postnatal Growth in Healthy Infants 0-3 Months of Age

Objective: The effect of ghrelin on growth of the newborn has long been argued, but not fully clarified. In this study, we aimed to investigate the relationship between ghrelin levels and growth parameters in the first 3...

Download PDF file
  • EP ID EP129095
  • DOI -
  • Views 113
  • Downloads 0

How To Cite

Feyza Darendeliler (2009). Safety of Growth Hormone Treatment. Journal of Clinical Research in Pediatric Endocrinology, 1(1), 36-43. https://europub.co.uk./articles/-A-129095